{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "9616339", "DateCompleted": {"Year": "1998", "Month": "06", "Day": "11"}, "DateRevised": {"Year": "2019", "Month": "05", "Day": "03"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "1355-6037", "JournalIssue": {"Volume": "79", "Issue": "4", "PubDate": {"Year": "1998", "Month": "Apr"}}, "Title": "Heart (British Cardiac Society)", "ISOAbbreviation": "Heart"}, "ArticleTitle": "Long-term survival effect of metoprolol in dilated cardiomyopathy. The SPIC (Italian Multicentre Cardiomyopathy Study) Group.", "Pagination": {"StartPage": "337", "EndPage": "344", "MedlinePgn": "337-44"}, "Abstract": {"AbstractText": ["To evaluate the additive effect of metoprolol treatment on long-term incidence of fatal and non-fatal cardiac events in idiopathic dilated cardiomyopathy.", "586 patients with idiopathic dilated cardiomyopathy were prospectively enrolled in a multicentre registry and followed up for a mean (SD) of 52 (32) months. Metoprolol, carefully titrated to the maximum tolerated dose, was added to conventional heart failure treatment in 175 patients.", "Survival and transplant-free survival at seven years were significantly higher in the 175 metoprolol treated patients than in the remaining 411 on standard treatment (81% v 60%, p < 0.001, and 69% v 49%, p < 0.001, respectively). By multivariate analysis, metoprolol independently predicted survival and transplant-free survival (relative risk reduction values for all cause mortality and combined mortality or transplantation 51% (95% confidence interval 21% to 69%), p = 0.002, and 34% (5% to 53%), p = 0.01, respectively). New York Heart Association class, left ventricular end diastolic diameter, and pulmonary wedge pressure were also predictive. Seven year survival (80% v 62%, p = 0.004) and transplant-free survival (68% v 51%, p = 0.005) were significantly higher in 127 metoprolol treated cases than in 127 controls selected from the entire control cohort and appropriately matched. Metoprolol was associated with a 30% reduction in all cause mortality (7% to 48%, p = 0.015) and a 26% reduction in mortality or transplantation (7% to 41%, p = 0.009).", "The addition of metoprolol to standard heart failure treatment, including angiotensin converting enzyme inhibitors, was effective in the long-term, reducing both all cause mortality and transplantation in patients with idiopathic dilated cardiomyopathy."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cardiology, Ospedale Maggiore and University, Trieste, Italy."}], "LastName": "Di Lenarda", "ForeName": "A", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "De Maria", "ForeName": "R", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Gavazzi", "ForeName": "A", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Gregori", "ForeName": "D", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Parolini", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Sinagra", "ForeName": "G", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Salvatore", "ForeName": "L", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Longaro", "ForeName": "F", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Bernobich", "ForeName": "E", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Camerini", "ForeName": "F", "Initials": "F"}], "PublicationTypeList": ["Journal Article", "Multicenter Study", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Heart", "NlmUniqueID": "9602087", "ISSNLinking": "1355-6037"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Adrenergic beta-Antagonists"}, {"RegistryNumber": "0", "NameOfSubstance": "Angiotensin-Converting Enzyme Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Diuretics"}, {"RegistryNumber": "7LXU5N7ZO5", "NameOfSubstance": "Furosemide"}, {"RegistryNumber": "GEB06NHM23", "NameOfSubstance": "Metoprolol"}], "MeshHeadingList": [{"QualifierName": ["therapeutic use"], "DescriptorName": "Adrenergic beta-Antagonists"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Angiotensin-Converting Enzyme Inhibitors"}, {"QualifierName": ["drug therapy", "mortality", "surgery"], "DescriptorName": "Cardiomyopathy, Dilated"}, {"QualifierName": [], "DescriptorName": "Digitalis"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Diuretics"}, {"QualifierName": [], "DescriptorName": "Drug Therapy, Combination"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Follow-Up Studies"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Furosemide"}, {"QualifierName": [], "DescriptorName": "Heart Transplantation"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Metoprolol"}, {"QualifierName": [], "DescriptorName": "Multivariate Analysis"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Plants, Toxic"}, {"QualifierName": [], "DescriptorName": "Prospective Studies"}, {"QualifierName": [], "DescriptorName": "Retrospective Studies"}, {"QualifierName": [], "DescriptorName": "Survival Rate"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "J Am Coll Cardiol. 1992 Jul;20(1):248-54", "ArticleIdList": ["1351488"]}, {"Citation": "Am J Cardiol. 1992 Jun 1;69(17):1451-7", "ArticleIdList": ["1590236"]}, {"Citation": "Lancet. 1993 Dec 11;342(8885):1441-6", "ArticleIdList": ["7902479"]}, {"Citation": "J Am Coll Cardiol. 1994 Mar 1;23(3):814-21", "ArticleIdList": ["7906702"]}, {"Citation": "Lancet. 1994 Aug 20;344(8921):493-8", "ArticleIdList": ["7914611"]}, {"Citation": "J Am Coll Cardiol. 1994 Dec;24(7):1678-87", "ArticleIdList": ["7963115"]}, {"Citation": "Circulation. 1994 Dec;90(6):2772-9", "ArticleIdList": ["7994820"]}, {"Citation": "Br Heart J. 1994 Dec;72(6 Suppl):S46-51", "ArticleIdList": ["7873326"]}, {"Citation": "N Engl J Med. 1995 Jul 13;333(2):77-82", "ArticleIdList": ["7539890"]}, {"Citation": "Circulation. 1995 Sep 15;92(6):1499-506", "ArticleIdList": ["7664433"]}, {"Citation": "G Ital Cardiol. 1995 Sep;25(9):1109-25", "ArticleIdList": ["8529848"]}, {"Citation": "N Engl J Med. 1996 May 23;334(21):1349-55", "ArticleIdList": ["8614419"]}, {"Citation": "N Engl J Med. 1996 May 23;334(21):1396-7", "ArticleIdList": ["8614427"]}, {"Citation": "J Am Coll Cardiol. 1997 Jul;30(1):27-34", "ArticleIdList": ["9207617"]}, {"Citation": "Br Heart J. 1980 Aug;44(2):117-33", "ArticleIdList": ["6107090"]}, {"Citation": "Lancet. 1981 Sep 5;2(8245):490-3", "ArticleIdList": ["6115247"]}, {"Citation": "Am J Cardiovasc Pathol. 1987 Jan;1(1):3-14", "ArticleIdList": ["3455232"]}, {"Citation": "Am J Med. 1990 Mar;88(3):223-9", "ArticleIdList": ["1968710"]}, {"Citation": "Circulation. 1990 Nov;82(5):1730-6", "ArticleIdList": ["2225374"]}, {"Citation": "J Am Coll Cardiol. 1991 May;17(6):1373-81", "ArticleIdList": ["1673132"]}, {"Citation": "J Am Coll Cardiol. 1993 Sep;22(3):808-15", "ArticleIdList": ["8354816"]}], "ReferenceList": []}], "History": [{"Year": "1998", "Month": "6", "Day": "9"}, {"Year": "1998", "Month": "6", "Day": "9", "Hour": "0", "Minute": "1"}, {"Year": "1998", "Month": "6", "Day": "9", "Hour": "0", "Minute": "0"}, {"Year": "2001", "Month": "4", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["9616339", "PMC1728660", "10.1136/hrt.79.4.337"]}}]}